Austco Healthcare Ltd · ASX:AHC
Austco Healthcare — Investor Presentation (March 2021)
23 slides from Austco Healthcare's investor presentation, March 2021
Slide 1: Investor Presentation
Investor Austco Healthcare Limited Presentation March 2021 Clayton Astles Brendan Maher CEO CFO 1
Slide 2: Agenda
Agenda Austco Healthcare Limited 1 Strategic Objectives 2 Market and Products 3 Financial Performance 4 Appendices 2
Slide 3: Strategic Objectives
3 Austco Healthcare Limited Strategic Objectives
Slide 4: FY21 Strategic Plan
FY21 Strategic Plan OBJECTIVE STRATEGY Progress Outsource high volume manufacturing to contract manufacturers 🟢 Improve margins Increase software and SMA sales revenue ➖ Recruit sales professionals in strategic locations, AU and 🟢 Drive revenue growth Asia added in CY20 Target national accounts…
Slide 5: Outlook
Outlook Revitalised operating platform Austco Healthcare Limited Market-leading products through sustained R&D commitment COVID uncertainties exist, offset by high level of Order Book Rapidly growing global marketplace, expected to grow even larger post COVID Investment in Sales and Marketing resour
Slide 6: Market & Products
6 Austco Healthcare Limited Market & Products
Slide 7: Industry trend: Real-time Health Communications
Industry trend: Real-time Health Communications Healthcare Infrastructure Austco Healthcare Limited Data from all systems accessible Data collection & sharing Initially for reporting, eventually for automation and machine learning Mobile-first IT Infrastructure Building Management 7
Slide 8: Pulse Mobile
Pulse Mobile Austco Healthcare Limited Secure text and freeform VOIP calls Task lists / reminders Assignments Rounding Advanced workflow Native nurse call system control 8
Slide 9: Tacera
Tacera Built-in RTLS Austco Healthcare Limited Real-time location has become a critical component to facilities due to its actionable data and efficiencies gained through automation. Uses existing nurse call infrastructure for a cost- effective solution Data and events drive automated processes Robu
Slide 10: Additional Built-in RTLS Features
Additional Built-in RTLS Features Austco Healthcare Limited Resident, asset tags Geofencing Advanced reporting Add capability to more Tacera elements 10
Slide 11: PST Lite / CCT2
PST Lite / CCT2 Austco Healthcare Limited Cost-effective room controller Multiple configurations Acute- and aged-care Built-in RTLS Enterprise ready 11
Slide 12: Financial Performance
12 Austco Healthcare Limited Financial Performance
Slide 13: 1HFY21 Financial Snapshot
1HFY21 Financial Snapshot Software & Revenue SMA revenues Margin $13.9M 51.4% 14% of revenue from customers ($2.9M) or (17%) Consistent with Austco Healthcare Limited on pcp pcp Same as pcp EBITDA NPAT Net Cash $1.6M $0.83M $6.3M $0.2M or 10% $0.02M or 2% Remains robust on pcp on pcp 13
Slide 14: Revenue
Revenue Other Income Revenue from customers at $13.9m continues to be Revenue from customers impacted by COVID-19, with restrictions impacting our ability to get on site to install. Our Open Sales Order book is (A$000S) the largest in the Company’s history, as such, we believe once COVID-19 restrict
Slide 15: Gross Profit + Margin
Gross Profit + Margin Gross margin % in 1HFY21 at 51.4% was a pleasing result 52.7% given the COVID-19 related supply chain cost increases, our 51.4% 51.4% recent focus on improving these margins demonstrates the value of this focus: 47.2% 8,630 Austco Healthcare Limited • By the end of 1HFY21 we ha
Slide 16: Earnings
Earnings REPORTED NPBT (A$000S) Profits were maintained in 1HFY21, despite the decrease in revenue, due to both cost reductions implemented during the 1,702 COVID-19 pandemic and Other Income: • Overhead expenses decreased to $6.8m from $7.7m in 1HFY20 due to implemented COVID-19 related costs 1,064
Slide 17: Cash + Debt
Cash + Debt CASH + DEBT (A$000S) • Cash on hand remains strong at $6.3m 6,447 6,340 6,061 • In late January 2021 we received a further $0.9m in USA COVID-19 related stimulus loan, similar to the loan received (and forgiven) in FY20. As with the first loan we Austco Healthcare Limited expect the majo
Slide 18: COVID-19
COVID-19 Impact of COVID-19 COVID-19 continues to impact Austco Healthcare. Whilst regions have been impacted to varying degrees, the recent lockdowns in New Zealand, Canada and Australia highlight this is an ongoing issue for us to manage. Production Access to sites • Whilst the majority of our sup
Slide 19: Appendices
19 Austco Healthcare Limited Appendices
Slide 20: Austco Dashboard
Austco Dashboard MARKET INFORMATION* SHARE PRICE MOVEMENT (12 MONTHS) SHARE REGISTER Shares on Issue 284,188,951 2% 25% Options on Issue 14.2M Market Cap $27.0M 52-Wk High $0.110 52-Wk Low $0.048 73% Current Share Price $0.095 Board and Management Institutional Shareholders Retail Shareholders FINAN
Slide 21: Global Market
Global Market 2,800 2,666 Strong global demand and the ongoing pressure for efficiencies in health budgets will underpin the GR 2,100 CA growth of sophisticated nurse call work flow 3% 11. Austco Healthcare Limited solutions. The market for nurse call systems is expected to more than double between
Slide 22: Disclaimer
Disclaimer This presentation was prepared by Austco Healthcare Limited and was respective affiliates, associates, shareholders, directors, officers, employees, authorised for release by the Board of the Company. agents, representatives and advisers (the Austco Parties) make any representation or war
Slide 23: Austco Healthcare Limited
Austco Healthcare Limited Clayton Astles CEO & Executive Director Telephone Aust: +61 411 531 170 Telephone US: +1 416 565 7457 Email: clayton.astles@austco.com Brendan Maher CFO & Company Secretary Telephone: +61 439 369 551 Email: brendan.maher@austco.com 23
Austco Healthcare — Investor Presentation (March 2021) on 6ix